Vermont law 33 V.S.A. §2005a mandates that pharmaceutical manufacturers disclose to Vermont physicians and other prescribers the average wholesale price (AWP) of drugs they market within the state as well as the prices of other drugs in the same therapeutic class. Under Vermont law, “therapeutic class” is defined as the therapeutic class listed in the 2004 American Hospital Formulary Service Pharmacologic-Therapeutic Classification published by the American Society of Health System Pharmacists (available at http://www.ashp.org/ahfs).
Shire has listed these therapeutic class prices in Long Form Disclosures as required under Vermont Law.
Access the Long Form Disclosure for:
Access the Short Form Disclosure for:
© 2020 Shire US Inc. Wayne, PA 19087 (800) 828-2088. All rights reserved.
While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.